The University at Buffalo has donated more than 200 reusable 3D-printed face masks and 100 face shields to the Buffalo City Mission for distribution to its clients and staff.
Front-line health care workers, including Jacobs School of Medicine and Biomedical Sciences faculty and medical residents, have begun receiving their COVID-19 vaccines, with some already receiving their second dose.
The first meeting of University at Buffalo’s Cancer Research Consortium was conducted virtually Dec. 10, where it was reported that faculty are working on 97 active cancer research awards totaling $7.4 million in annual direct funding.
Thomas D. Grant, PhD, assistant professor of structural biology, is co-principal investigator on a grant from the National Science Foundation (NSF) to study how small molecules bind to the SARS-COV-2 protease to understand drug binding and help aid drug design.
Memory loss associated with Alzheimer’s disease may be able to be treated by inhibiting certain enzymes involved in abnormal gene transcription, according to a preclinical study led by senior author Zhen Yan, PhD.
At the start of the pandemic, research teams around the world began conducting studies to help further research related to vaccines for the SARS-CoV-2 coronavirus. A team led by Jonathan F. Lovell, PhD, was one of them.
Joseph Terrell Smith Jr., PhD, postdoctoral fellow in microbiology and immunology, has been awarded a three-year, $202,000 F32 grant from the National Institute of Allergy and Infectious Diseases to study the regulation of RNA in Trypanosoma brucei.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a computational approach to make drug discovery faster and less expensive while also being safe and effective.
A Phase 2 research study led by Teresa Quattrin, MD, UB Distinguished Professor of pediatrics and senior associate dean for research integration, shows that the drug golimumab preserves beta-cell function in children and young adults with newly-diagnosed Type 1 diabetes for at least a year after diagnosis.
Michael W. Russell, PhD, professor emeritus of microbiology and immunology, says more COVID-19 studies should be devoted to how immunity emerges to SARS-CoV-2 in the mucous membranes of the nose and mouth.
Holiday dinner conversations sometimes erupt in heated discussions when friends and relatives with opposing political views get together. This year, whether or not to even host the dinner may be a volatile topic all by itself.
Gil I. Wolfe, MD, UB Distinguished Professor and the Irvin and Rosemary Smith Chair of neurology, served as co-chair for a panel composed of 16 international experts on myasthenia gravis (MG) who revised and expanded recommendations for managing the disease.
Thomas C. Rosenthal, MD, has written a book that examines how doctors dealt with community health crises in earlier times, without the medical advancements and technologies available to researchers in the 21st century.
In a landmark study, researchers found that a combination of biomarkers in saliva can help objectively and accurately diagnose mild traumatic brain injury.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have published a paper that is helping to define the best time to give a specific treatment to infants born with Krabbe disease (KD).
Cytocybernetics, the UB spinoff co-founded by two Jacobs School of Medicine and Biomedical Sciences faculty members, is aiding in the effort to clear candidate drug therapies for COVID-19 in a fast, effective and safe manner.
Western New Yorkers who were recently exposed to a household member who has tested positive for COVID-19 now have an opportunity to be treated with a promising drug being investigated for COVID-19 infection.
Agents that enhance the immune response to foreign molecules, called adjuvants, will likely play a role in developing a successful COVID-19 vaccine, according to Terry D. Connell, PhD, professor of microbiology and immunology.
Team Alice, an initiative of the University at Buffalo’s Center for Successful Aging, has been awarded a $60,000 grant from the U.S. Deprescribing Research Network (USDeN) to evaluate an educational video designed to encourage patient/caregiver-initiated deprescribing conversations with doctors and to evaluate its impact on medication use.
